financetom
Business
financetom
/
Business
/
--SS&C Technologies Keeps Quarterly Dividend at $0.25 a Share, Payable Dec. 16 to Shareholders of Record on Dec. 2
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--SS&C Technologies Keeps Quarterly Dividend at $0.25 a Share, Payable Dec. 16 to Shareholders of Record on Dec. 2
Nov 21, 2024 10:22 AM

11:25 AM EST, 11/21/2024 (MT Newswires) --

Price: 74.82, Change: +1.38, Percent Change: +1.89

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: McDonald's, Supermarkets Failed to Spot Forced Labor of Workers in UK
Market Chatter: McDonald's, Supermarkets Failed to Spot Forced Labor of Workers in UK
Oct 2, 2024
07:58 AM EDT, 09/30/2024 (MT Newswires) -- Signs that a gang forced 16 victims to work at either McDonald's (MCD) or a factory that supplied bread products to major supermarkets were missed for years, the BBC reported Monday. Several signs of forced labor, including paying the wages of four men into one bank account, were not identified over the four...
TD Comments on Canada's Economy
TD Comments on Canada's Economy
Oct 2, 2024
07:57 AM EDT, 09/30/2024 (MT Newswires) -- It's been clear for some time that the Canadian economy is operating with slack, said TD. The Bank of Canada certainly reinforced as much in its summer Monetary Policy Report, but perhaps the clearest signal is that Canada's unemployment rate has jumped 1.6 percentage points from its 2023 low, noted the bank. Last...
Alterity Therapeutics Appoints Abby Niven as CFO
Alterity Therapeutics Appoints Abby Niven as CFO
Oct 2, 2024
07:58 AM EDT, 09/30/2024 (MT Newswires) -- Alterity Therapeutics ( ATHE ) said on Monday it appointed Abby Niven to succeed Phillip Hains as chief financial officer, effective today. Niven has extensive experience in private wealth management with groups including ANZ, UBS and Ord Minett and consults on governance, finance, and corporate structure for various companies. Hains continues as company...
Adicet Bio Begins Phase 1 Trial Enrollment for Potential Autoimmune Diseases Therapy
Adicet Bio Begins Phase 1 Trial Enrollment for Potential Autoimmune Diseases Therapy
Oct 2, 2024
07:55 AM EDT, 09/30/2024 (MT Newswires) -- Adicet Bio ( ACET ) said Monday it has opened enrollment for its phase 1 trial evaluating ADI-001, an investigational allogeneic gamma delta CAR T cell therapy, in autoimmune diseases. The company said it is enrolling patients with lupus nephritis and plans to accept patients with systemic lupus erythematosus, systemic sclerosis, and anti-neutrophil...
Copyright 2023-2026 - www.financetom.com All Rights Reserved